General
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been peer-reviewed, showed that the immunosuppressive drugs — Actemra, also known as tocilizumab, and Kevzara, also known as sarilumab — reduced death rates by 8.5 percentage points among patients hospitalised and severely ill with the pandemic…
-
General21 hours agoMan charged with murder after alleged assault victim dies in Hervey Bay
-
General16 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News20 hours agoPublic health alert for nitazenes issued after person dies in Queensland
-
Business20 hours agoWhat’s Macquarie’s price target on Mineral Resources shares?